The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Inflammation is important in the both pathogenesis and outcome of atherosclerosis. Plaques
containing numerous inflammatory cells, particular macrophages, have a high risk of
rupture.We hypothesize that statin-induced plaque regression could be monitored clinically by
use of FDG PET/CT approach, and can be detected noninvasively earlier than previously
reported.